To study the oncolytic efficacy and safety of oncolytic virus, scientists in Creative Biolabs has developed a comprehensive set of in vitro and in vivo assays. Since oncolytic virus is a kind of gene therapeutic product which is designed to be replication-competent, there are specific technical challenges for its characterization.